Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against CV Sciences, Inc. (“CV Sciences” or the “Company”) (OTCMKT: CVSI) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired CV Sciences securities between June 19, 2017 and August 20, 2018
| NEW YORK, /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against CV Sciences, Inc. (“CV Sciences” or the “Company”) (OTCMKT: CVSI) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired CV Sciences securities between June 19, 2017 and August 20, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/cvsi. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that its Patent #15/426,617: (1) received a non-final rejection from the USPTO on April 27, 2017; (2) a final rejection from the USPTO on December 14, 2017; and (3) consequently, Defendants’ statements about CV Sciences’ business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis. On August 20, 2018, Citron Research alleged that CV Sciences misrepresented the status of one of its key patents. Citron Research said that the Company failed to disclose a rejected patent that the Company “continue[d] to hype.” Following this news, CV Sciences stock dropped over 63%. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/cvsi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in CV Sciences you have until October 23, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact:
View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert---bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-against-cv-sciences-inc-cvsi-and-lead-plaintiff-deadline---october-23-2018-300703901.html SOURCE Bronstein, Gewirtz & Grossman, LLC | ||
Company Codes: OTC-PINK:CVSI, OTC-QB:CVSI |
